← FDA Drug Approvals (Drugs@FDA)

COPIKTRA

NDA · New Drug Application · Sponsor: SECURA · Approved 2018-09-24

Drug application

FDA Application #

NDA211155

Application type

New Drug Application

Brand name

COPIKTRA

Generic name

DUVELISIB

Active ingredients

DUVELISIB

Dosage form

CAPSULE

Route

ORAL

Marketing status

Prescription

Sponsor

SECURA

Manufacturer

Secura Bio, Inc

First approval

2018-09-24

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown